Coverage of "GLP-1" on Cryptosearcher: the stories and the context behind them.
Eli Lilly beat earnings and raised guidance on strong GLP-1 sales, but the stock surged then collapsed by close, erasing the entire gap and forming a rejection candle.
August 5, 2026
